0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biosimilar Drug Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-13155
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Biosimilar Drug Market Insights Forecast to 2025

Global Biosimilar Drug Market Insights, Forecast to 2025

Code: QYRE-Auto-13155
Report
May 2019
116 Pages
QYResearch
Region: Global, China, Germany, UK,
Description
Table of Content
Tables & Figures
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars. First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%. Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars. Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry. Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries. At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.
The global Biosimilar Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biosimilar Drug market based on company, product type, end user and key regions.

This report studies the global market size of Biosimilar Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar Drug in these regions.
This research report categorizes the global Biosimilar Drug market by top players/brands, region, type and end user. This report also studies the global Biosimilar Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Amgen
    Eli Lilly
    Novartis
    CP Guojian Pharma
    Biotech Pharma

Market size by Product
    Injection
    Tablets
    Other Types
Market size by End User
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Biosimilar Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Biosimilar Drug market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Biosimilar Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Biosimilar Drug submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biosimilar Drug are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K DDD). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilar Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Biosimilar Drug Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Biosimilar Drug Market Size Growth Rate by Product
        1.4.2 Injection
        1.4.3 Tablets
        1.4.4 Other Types
    1.5 Market by End User
        1.5.1 Global Biosimilar Drug Market Size Growth Rate by End User
        1.5.2 Ankylosing Spondylitis
        1.5.3 Tumor
        1.5.4 Rheumatoid Arthrtis
        1.5.5 Cardiovascular
        1.5.6 Other Application
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Biosimilar Drug Market Size
        2.1.1 Global Biosimilar Drug Revenue 2014-2025
        2.1.2 Global Biosimilar Drug Sales 2014-2025
    2.2 Biosimilar Drug Growth Rate by Regions
        2.2.1 Global Biosimilar Drug Sales by Regions
        2.2.2 Global Biosimilar Drug Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Biosimilar Drug Sales by Manufacturers
        3.1.1 Biosimilar Drug Sales by Manufacturers
        3.1.2 Biosimilar Drug Sales Market Share by Manufacturers
        3.1.3 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI)
    3.2 Biosimilar Drug Revenue by Manufacturers
        3.2.1 Biosimilar Drug Revenue by Manufacturers (2014-2019)
        3.2.2 Biosimilar Drug Revenue Share by Manufacturers (2014-2019)
    3.3 Biosimilar Drug Price by Manufacturers
    3.4 Biosimilar Drug Manufacturing Base Distribution, Product Types
        3.4.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Biosimilar Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Biosimilar Drug Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Biosimilar Drug Sales by Product
    4.2 Global Biosimilar Drug Revenue by Product
    4.3 Biosimilar Drug Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Biosimilar Drug Breakdown Data by End User

6 North America
    6.1 North America Biosimilar Drug by Countries
        6.1.1 North America Biosimilar Drug Sales by Countries
        6.1.2 North America Biosimilar Drug Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Biosimilar Drug by Product
    6.3 North America Biosimilar Drug by End User

7 Europe
    7.1 Europe Biosimilar Drug by Countries
        7.1.1 Europe Biosimilar Drug Sales by Countries
        7.1.2 Europe Biosimilar Drug Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Biosimilar Drug by Product
    7.3 Europe Biosimilar Drug by End User

8 Asia Pacific
    8.1 Asia Pacific Biosimilar Drug by Countries
        8.1.1 Asia Pacific Biosimilar Drug Sales by Countries
        8.1.2 Asia Pacific Biosimilar Drug Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Biosimilar Drug by Product
    8.3 Asia Pacific Biosimilar Drug by End User

9 Central & South America
    9.1 Central & South America Biosimilar Drug by Countries
        9.1.1 Central & South America Biosimilar Drug Sales by Countries
        9.1.2 Central & South America Biosimilar Drug Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Biosimilar Drug by Product
    9.3 Central & South America Biosimilar Drug by End User

10 Middle East and Africa
    10.1 Middle East and Africa Biosimilar Drug by Countries
        10.1.1 Middle East and Africa Biosimilar Drug Sales by Countries
        10.1.2 Middle East and Africa Biosimilar Drug Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Biosimilar Drug by Product
    10.3 Middle East and Africa Biosimilar Drug by End User

11 Company Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Company Business Overview
        11.1.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Amgen Biosimilar Drug Products Offered
        11.1.5 Amgen Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Company Business Overview
        11.2.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Eli Lilly Biosimilar Drug Products Offered
        11.2.5 Eli Lilly Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Company Business Overview
        11.3.3 Novartis Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Novartis Biosimilar Drug Products Offered
        11.3.5 Novartis Recent Development
    11.4 CP Guojian Pharma
        11.4.1 CP Guojian Pharma Company Details
        11.4.2 Company Business Overview
        11.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 CP Guojian Pharma Biosimilar Drug Products Offered
        11.4.5 CP Guojian Pharma Recent Development
    11.5 Biotech Pharma
        11.5.1 Biotech Pharma Company Details
        11.5.2 Company Business Overview
        11.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Biotech Pharma Biosimilar Drug Products Offered
        11.5.5 Biotech Pharma Recent Development

12 Future Forecast
    12.1 Biosimilar Drug Market Forecast by Regions
        12.1.1 Global Biosimilar Drug Sales Forecast by Regions 2019-2025
        12.1.2 Global Biosimilar Drug Revenue Forecast by Regions 2019-2025
    12.2 Biosimilar Drug Market Forecast by Product
        12.2.1 Global Biosimilar Drug Sales Forecast by Product 2019-2025
        12.2.2 Global Biosimilar Drug Revenue Forecast by Product 2019-2025
    12.3 Biosimilar Drug Market Forecast by End User
    12.4 North America Biosimilar Drug Forecast
    12.5 Europe Biosimilar Drug Forecast
    12.6 Asia Pacific Biosimilar Drug Forecast
    12.7 Central & South America Biosimilar Drug Forecast
    12.8 Middle East and Africa Biosimilar Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Biosimilar Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Biosimilar Drug Product Picture
    Table Biosimilar Drug Market Segments
    Table Key Manufacturers Biosimilar Drug Covered
    Table Global Biosimilar Drug Market Size Growth Rate by Product 2019-2025 (K DDD) & (Million US$)
    Figure Global Biosimilar Drug Sales Market Share by Product 2014-2025
    Figure Injection Product Picture
    Table Major Manufacturers of Injection
    Figure Tablets Product Picture
    Table Major Manufacturers of Tablets
    Figure Other Types Product Picture
    Table Major Manufacturers of Other Types
    Table Global Biosimilar Drug Market Size Growth Rate by End User 2019-2025 (K DDD)
    Figure Ankylosing Spondylitis
    Figure Tumor
    Figure Rheumatoid Arthrtis
    Figure Cardiovascular
    Figure Other Application
    Figure Biosimilar Drug Report Years Considered
    Figure Global Biosimilar Drug Market Size 2014-2025 (Million US$)
    Figure Global Biosimilar Drug Sales 2014-2025 (K DDD)
    Table Global Biosimilar Drug Market Size by Regions 2014-2019 (K DDD) & (Million US$)
    Table Global Biosimilar Drug Sales by Regions 2014-2019 (K DDD)
    Table Global Biosimilar Drug Sales Market Share by Regions 2014-2019
    Figure Global Biosimilar Drug Sales Market Share by Regions 2014-2019
    Figure 2018 Global Biosimilar Drug Sales Market Share by Regions
    Table Global Biosimilar Drug Revenue by Regions 2014-2019 (Million US$)
    Table Global Biosimilar Drug Revenue Market Share by Regions 2014-2019
    Figure Global Biosimilar Drug Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Biosimilar Drug Revenue Market Share by Regions
    Table Global Biosimilar Drug Sales by Manufacturers (2014-2019) (K DDD)
    Table Global Biosimilar Drug Sales Share by Manufacturers (2014-2019)
    Figure Global Biosimilar Drug Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Biosimilar Drug Revenue by Manufacturers (2014-2019) (Million USD)
    Table Biosimilar Drug Revenue Share by Manufacturers (2014-2019)
    Figure Biosimilar Drug Value Share by Manufacturers in 2018
    Table Key Manufacturers Biosimilar Drug Price (2014-2019) (USD/DDD)
    Table Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Biosimilar Drug Product Type
    Table Date of International Manufacturers Enter into Biosimilar Drug Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Biosimilar Drug Sales by Product (2014-2019) (K DDD)
    Table Global Biosimilar Drug Sales Share by Product (2014-2019)
    Figure Global Biosimilar Drug Sales Market Share by Product (2014-2019)
    Figure Global Biosimilar Drug Sales Market Share by Product in 2018
    Table Global Biosimilar Drug Revenue by Product (2014-2019) (Million US$)
    Table Global Biosimilar Drug Revenue Share by Product (2014-2019)
    Figure Global Biosimilar Drug Revenue Market Share by Product (2014-2019)
    Figure Global Biosimilar Drug Revenue Market Share by Product in 2018
    Table Biosimilar Drug Price by Product 2014-2019 (USD/DDD)
    Table Global Biosimilar Drug Sales by End User (2014-2019) (K DDD)
    Table Global Biosimilar Drug Sales Share by End User (2014-2019)
    Figure Global Sales Biosimilar Drug Market Share by End User (2014-2019)
    Figure Global Sales Biosimilar Drug Market Share by End User in 2018
    Figure North America Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
    Figure North America Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
    Table North America Biosimilar Drug Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Biosimilar Drug Sales Market Share by Countries
    Table North America Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
    Table North America Biosimilar Drug Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Biosimilar Drug Revenue Market Share by Countries
    Figure United States Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure United States Biosimilar Drug Revenue Growth Rate (2014-2019) (K DDD)
    Figure Canada Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Canada Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Mexico Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Biosimilar Drug Sales by Product (2014-2019) (K DDD)
    Table North America Biosimilar Drug Sales Market Share by Product (2014-2019)
    Figure 2018 North America Biosimilar Drug Market Share by Product
    Table North America Biosimilar Drug Sales by End User (2014-2019) (K DDD)
    Table North America Biosimilar Drug Sales Market Share by End User (2014-2019)
    Figure 2018 North America Biosimilar Drug Market Share by End User
    Figure Europe Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
    Figure Europe Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
    Table Europe Biosimilar Drug Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Biosimilar Drug Sales Market Share by Countries
    Table Europe Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
    Table Europe Biosimilar Drug Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Biosimilar Drug Revenue Market Share by Countries
    Figure Germany Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Germany Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure France Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure UK Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Italy Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Russia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Biosimilar Drug Sales by Product (2014-2019) (K DDD)
    Table Europe Biosimilar Drug Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Biosimilar Drug Market Share by Product
    Table Europe Biosimilar Drug Sales by End User (2014-2019) (K DDD)
    Table Europe Biosimilar Drug Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Biosimilar Drug Market Share by End User
    Figure Asia Pacific Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
    Figure Asia Pacific Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
    Table Asia Pacific Biosimilar Drug Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Drug Sales Market Share by Countries
    Table Asia Pacific Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Biosimilar Drug Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Drug Revenue Market Share by Countries
    Figure China Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure China Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Japan Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Korea Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure India Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Australia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Indonesia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Malaysia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Philippines Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Thailand Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Vietnam Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Singapore Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Biosimilar Drug Sales by Product (2014-2019) (K DDD)
    Table Asia Pacific Biosimilar Drug Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Drug Market Share by Product
    Table Asia Pacific Biosimilar Drug Sales by End User (2014-2019) (K DDD)
    Table Asia Pacific Biosimilar Drug Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Biosimilar Drug Market Share by End User
    Figure Central & South America Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
    Figure Central & South America Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
    Table Central & South America Biosimilar Drug Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Biosimilar Drug Sales Market Share by Countries
    Table Central & South America Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Biosimilar Drug Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Biosimilar Drug Revenue Market Share by Countries
    Figure Brazil Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Brazil Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Argentina Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Biosimilar Drug Sales by Product (2014-2019) (K DDD)
    Table Central & South America Biosimilar Drug Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Biosimilar Drug Market Share by Product
    Table Central & South America Biosimilar Drug Sales by End User (2014-2019) (K DDD)
    Table Central & South America Biosimilar Drug Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Biosimilar Drug Market Share by End User
    Figure Middle East and Africa Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
    Figure Middle East and Africa Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
    Table Middle East and Africa Biosimilar Drug Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Drug Sales Market Share by Countries
    Table Middle East and Africa Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Biosimilar Drug Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Drug Revenue Market Share by Countries
    Figure GCC Countries Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure GCC Countries Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Turkey Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure Egypt Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
    Figure South Africa Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Biosimilar Drug Sales by Product (2014-2019) (K DDD)
    Table Middle East and Africa Biosimilar Drug Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Drug Market Share by Product
    Table Middle East and Africa Biosimilar Drug Sales by End User (2014-2019) (K DDD)
    Table Middle East and Africa Biosimilar Drug Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Biosimilar Drug Market Share by End User
    Table Amgen Company Details
    Table Amgen Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
    Table Amgen Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
    Table Eli Lilly Recent Development
    Table Novartis Company Details
    Table Novartis Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
    Table Novartis Recent Development
    Table CP Guojian Pharma Company Details
    Table CP Guojian Pharma Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
    Table CP Guojian Pharma Recent Development
    Table Biotech Pharma Company Details
    Table Biotech Pharma Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
    Table Biotech Pharma Recent Development
    Table Global Biosimilar Drug Sales Forecast by Regions 2019-2025 (K DDD)
    Table Global Biosimilar Drug Sales Market Share Forecast by Regions 2019-2025
    Table Global Biosimilar Drug Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Biosimilar Drug Revenue Market Share Forecast by Regions 2019-2025
    Table Global Biosimilar Drug Sales Forecast by Product 2019-2025 (K DDD)
    Table Global Biosimilar Drug Sales Market Share Forecast by Product 2019-2025
    Table Global Biosimilar Drug Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Biosimilar Drug Revenue Market Share Forecast by Product 2019-2025
    Table Global Biosimilar Drug Sales Forecast by End User 2019-2025 (K DDD)
    Table Global Biosimilar Drug Sales Market Share Forecast by End User 2019-2025
    Figure North America Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
    Figure North America Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
    Figure Europe Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
    Figure Asia Pacific Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
    Figure Central & South America Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
    Figure Middle East and Africa Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Biosimilar Drug Value Chain
    Table Biosimilar Drug Customers List
    Table Biosimilar Drug Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Cytotoxicity Assay Market Size Status and Forecast 2021 2027
Global Cytotoxicity Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-39V907
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Aquaculture Vaccine Market Size Status and Forecast 2021 2027
Global Aquaculture Vaccine Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3I3192
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Intranasal Corticosteroids Market Size Status and Forecast 2021 2027
Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25X2634
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Tumor Tracking System Market Size Status and Forecast 2021 2027
Global Tumor Tracking System Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21F2812
Sun Jul 18 00:00:00 UTC 2021

Add to Cart